Annual Book Value
N/A
December 1, 2024
Summary
- PFE annual book value is not available.
Performance
PFE Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Book Value
N/A
December 1, 2024
Summary
- PFE quarterly book value is not available.
Performance
PFE Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
PFE Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $92.29 B(+5.2%) |
| Jun 2024 | - | $87.70 B(-5.0%) |
| Mar 2024 | - | $92.28 B(+3.7%) |
| Dec 2023 | $89.01 B(-6.9%) | $89.01 B(-8.2%) |
| Sep 2023 | - | $96.93 B(-2.1%) |
| Jun 2023 | - | $99.02 B(-1.9%) |
| Mar 2023 | - | $100.97 B(+5.5%) |
| Dec 2022 | $95.66 B(+23.9%) | $95.66 B(+3.3%) |
| Sep 2022 | - | $92.63 B(+6.2%) |
| Jun 2022 | - | $87.21 B(+5.8%) |
| Mar 2022 | - | $82.42 B(+6.8%) |
| Dec 2021 | $77.20 B(+22.1%) | $77.20 B(+2.0%) |
| Sep 2021 | - | $75.69 B(+8.1%) |
| Jun 2021 | - | $70.04 B(+2.1%) |
| Mar 2021 | - | $68.62 B(+8.5%) |
| Dec 2020 | $63.24 B(+0.2%) | $63.24 B(-3.1%) |
| Sep 2020 | - | $65.26 B(+1.4%) |
| Jun 2020 | - | $64.34 B(-1.0%) |
| Mar 2020 | - | $65.01 B(+3.0%) |
| Dec 2019 | $63.13 B(-0.4%) | $63.13 B(-3.0%) |
| Sep 2019 | - | $65.08 B(+9.3%) |
| Jun 2019 | - | $59.55 B(+1.3%) |
| Mar 2019 | - | $58.79 B(-7.3%) |
| Dec 2018 | $63.39 B(-11.1%) | $63.39 B(-11.1%) |
| Sep 2018 | - | $71.30 B(+2.2%) |
| Jun 2018 | - | $69.76 B(-0.6%) |
| Mar 2018 | - | $70.16 B(-1.6%) |
| Dec 2017 | $71.29 B(+19.8%) | $71.29 B(+17.3%) |
| Sep 2017 | - | $60.75 B(+4.1%) |
| Jun 2017 | - | $58.34 B(-0.1%) |
| Mar 2017 | - | $58.41 B(-1.9%) |
| Dec 2016 | $59.52 B(-8.0%) | $59.52 B(-5.9%) |
| Sep 2016 | - | $63.28 B(+0.9%) |
| Jun 2016 | - | $62.74 B(-0.5%) |
| Mar 2016 | - | $63.04 B(-2.6%) |
| Dec 2015 | $64.69 B(-9.2%) | $64.69 B(-3.2%) |
| Sep 2015 | - | $66.81 B(-0.1%) |
| Jun 2015 | - | $66.87 B(-0.6%) |
| Mar 2015 | - | $67.28 B(-5.6%) |
| Dec 2014 | $71.27 B(-6.6%) | $71.27 B(-8.6%) |
| Sep 2014 | - | $77.96 B(+1.8%) |
| Jun 2014 | - | $76.60 B(-1.5%) |
| Mar 2014 | - | $77.74 B(+1.9%) |
| Dec 2013 | $76.27 B(-6.1%) | $76.27 B(-2.1%) |
| Sep 2013 | - | $77.93 B(-0.7%) |
| Jun 2013 | - | $78.51 B(-4.5%) |
| Mar 2013 | - | $82.21 B(+1.2%) |
| Dec 2012 | $81.22 B(-1.1%) | $81.22 B(-0.5%) |
| Sep 2012 | - | $81.66 B(+2.7%) |
| Jun 2012 | - | $79.50 B(-4.5%) |
| Mar 2012 | - | $83.21 B(+1.3%) |
| Dec 2011 | $82.14 B(-6.4%) | $82.14 B(-8.7%) |
| Sep 2011 | - | $90.00 B(+1.8%) |
| Jun 2011 | - | $88.43 B(-1.8%) |
| Mar 2011 | - | $90.02 B(+2.6%) |
| Dec 2010 | $87.76 B(-2.4%) | $87.76 B(+0.2%) |
| Sep 2010 | - | $87.58 B(+1.4%) |
| Jun 2010 | - | $86.38 B(-3.6%) |
| Mar 2010 | - | $89.60 B(-0.4%) |
| Dec 2009 | $89.95 B(+56.5%) | $89.95 B(+36.1%) |
| Sep 2009 | - | $66.09 B(+5.0%) |
| Jun 2009 | - | $62.98 B(+4.6%) |
| Mar 2009 | - | $60.19 B(+4.7%) |
| Dec 2008 | $57.48 B(-11.5%) | $57.48 B(-14.5%) |
| Sep 2008 | - | $67.26 B(+1.2%) |
| Jun 2008 | - | $66.49 B(-1.3%) |
| Mar 2008 | - | $67.33 B(+3.7%) |
| Dec 2007 | $64.92 B(-8.8%) | $64.92 B(-2.4%) |
| Sep 2007 | - | $66.51 B(-2.2%) |
| Jun 2007 | - | $67.98 B(-6.1%) |
| Mar 2007 | - | $72.36 B(+1.6%) |
| Dec 2006 | $71.22 B | $71.22 B(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $69.57 B(+1.8%) |
| Jun 2006 | - | $68.34 B(-1.6%) |
| Mar 2006 | - | $69.45 B(+5.9%) |
| Dec 2005 | $65.59 B(-3.7%) | $65.59 B(-1.6%) |
| Sep 2005 | - | $66.63 B(+2.3%) |
| Jun 2005 | - | $65.15 B(-3.3%) |
| Mar 2005 | - | $67.34 B(-1.1%) |
| Dec 2004 | $68.08 B(+4.5%) | $68.08 B(-0.1%) |
| Sep 2004 | - | $68.18 B(+2.5%) |
| Jun 2004 | - | $66.50 B(-3.4%) |
| Mar 2004 | - | $68.84 B(+5.6%) |
| Dec 2003 | $65.16 B(+226.6%) | $65.16 B(-4.6%) |
| Sep 2003 | - | $68.30 B(-2.5%) |
| Jun 2003 | - | $70.04 B(+181.9%) |
| Mar 2003 | - | $24.84 B(+24.5%) |
| Dec 2002 | $19.95 B(+9.1%) | $19.95 B(+5.3%) |
| Sep 2002 | - | $18.95 B(+0.7%) |
| Jun 2002 | - | $18.83 B(-4.3%) |
| Mar 2002 | - | $19.67 B(+7.5%) |
| Dec 2001 | $18.29 B(+13.8%) | $18.29 B(-3.2%) |
| Sep 2001 | - | $18.90 B(+6.1%) |
| Jun 2001 | - | $17.82 B(+0.4%) |
| Mar 2001 | - | $17.75 B(+10.4%) |
| Dec 2000 | $16.08 B(+15.2%) | $16.08 B(-0.6%) |
| Sep 2000 | - | $16.17 B(+8.0%) |
| Jun 2000 | - | $14.97 B(+47.0%) |
| Mar 2000 | - | $10.19 B(-27.0%) |
| Dec 1999 | $13.95 B(+58.3%) | $13.95 B(+58.8%) |
| Sep 1999 | - | $8.79 B(+1.6%) |
| Jun 1999 | - | $8.65 B(-4.4%) |
| Mar 1999 | - | $9.04 B(+2.7%) |
| Dec 1998 | $8.81 B(+11.1%) | $8.81 B(+1.9%) |
| Sep 1998 | - | $8.64 B(+4.1%) |
| Jun 1998 | - | $8.30 B(+1.4%) |
| Mar 1998 | - | $8.19 B(+3.2%) |
| Dec 1997 | $7.93 B(+14.1%) | $7.93 B(+7.1%) |
| Sep 1997 | - | $7.41 B(+3.2%) |
| Jun 1997 | - | $7.17 B(+0.3%) |
| Mar 1997 | - | $7.15 B(+2.8%) |
| Dec 1996 | $6.95 B(+26.3%) | $6.95 B(+5.9%) |
| Sep 1996 | - | $6.57 B(+9.7%) |
| Jun 1996 | - | $5.98 B(+1.6%) |
| Mar 1996 | - | $5.89 B(+6.9%) |
| Dec 1995 | $5.51 B(+27.4%) | $5.51 B(+4.3%) |
| Sep 1995 | - | $5.28 B(+9.4%) |
| Jun 1995 | - | $4.83 B(+2.8%) |
| Mar 1995 | - | $4.70 B(+8.6%) |
| Dec 1994 | $4.32 B(+11.9%) | $4.32 B(+4.1%) |
| Sep 1994 | - | $4.15 B(+10.8%) |
| Jun 1994 | - | $3.75 B(-2.4%) |
| Mar 1994 | - | $3.84 B(-0.7%) |
| Dec 1993 | $3.87 B(-18.1%) | $3.87 B(+1.1%) |
| Sep 1993 | - | $3.82 B(-9.2%) |
| Jun 1993 | - | $4.21 B(-5.5%) |
| Mar 1993 | - | $4.45 B(-5.6%) |
| Dec 1992 | $4.72 B(-6.1%) | $4.72 B(-13.7%) |
| Sep 1992 | - | $5.47 B(+8.7%) |
| Jun 1992 | - | $5.03 B(-0.6%) |
| Mar 1992 | - | $5.06 B(+0.7%) |
| Dec 1991 | $5.03 B(-1.3%) | $5.03 B(-0.9%) |
| Sep 1991 | - | $5.07 B(+5.0%) |
| Jun 1991 | - | $4.83 B(-6.8%) |
| Mar 1991 | - | $5.18 B(+1.7%) |
| Dec 1990 | $5.09 B(+12.3%) | $5.09 B(+1.6%) |
| Sep 1990 | - | $5.01 B(+7.1%) |
| Jun 1990 | - | $4.68 B(-1.3%) |
| Mar 1990 | - | $4.74 B(+4.5%) |
| Dec 1989 | $4.54 B(+5.5%) | $4.54 B(+5.5%) |
| Dec 1988 | $4.30 B(+10.8%) | $4.30 B(+10.8%) |
| Dec 1987 | $3.88 B(+13.7%) | $3.88 B(+13.7%) |
| Dec 1986 | $3.42 B(+16.7%) | $3.42 B(+16.7%) |
| Dec 1985 | $2.93 B(+17.8%) | $2.93 B(+17.8%) |
| Dec 1984 | $2.48 B | $2.48 B |
FAQ
- What is the all time high annual book value for Pfizer?
- What is the all time high quarterly book value for Pfizer?
What is the all time high annual book value for Pfizer?
Pfizer all-time high annual book value is $95.66 B
What is the all time high quarterly book value for Pfizer?
Pfizer all-time high quarterly book value is $100.97 B